CD4 and neoplasm: characterized a population of CD4+ PD‐1+ TCF1+ T cells with stem‐like properties, capable of self‐renewal and differentiation into Th1 cells, which enhance tumor control and improve responsiveness to immunotherapy.[127] Similarly, Bassez et al.